The spectrum of olive pollen allergens

Citation
R. Rodriguez et al., The spectrum of olive pollen allergens, INT A AL IM, 125(3), 2001, pp. 185-195
Citations number
82
Categorie Soggetti
Immunology
Journal title
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
ISSN journal
10182438 → ACNP
Volume
125
Issue
3
Year of publication
2001
Pages
185 - 195
Database
ISI
SICI code
1018-2438(200107)125:3<185:TSOOPA>2.0.ZU;2-M
Abstract
Olive pollen is one of the most important causes of seasonal respiratory al lergy in Mediterranean countries, where this tree is intensely cultivated. Among the high number of protein allergens detected in this pollen, 8 - Ole e 1 to Ole e 8 - have been isolated and characterized. Ole e 1 is the most frequent sensitizing agent, affecting more than 70% of the patients suffer ing of olive pollinosis, although others, such as Ole e 4 and Ole e 7, have also been shown to be major allergens. In this context, the prevalence of many olive pollen allergens seems to be dependent on the geographical area where the sensitized patients live. Some of the olive allergens have been r evealed as members of known protein families: profilin (Ole e 2), Ca2+-bind ing proteins (Ole e 3 and Ole e 8), superoxide dismutase (Ole e 5) and lipi d transfer protein (Ole e 7). No biological function has been demonstrated for Ole e 1, whereas Ole e 4 and Ole e 6 are new proteins without homology to known sequences from databases. cDNAs encoding for Ole e 1, Ole e 3 and Ole e 8 have been overproduced in heterologous systems. The recombinant pro ducts were correctly folded and exhibited the functional activities of the natural allergens. In addition to the Oleaceae family, other species, such as Gramineae or Betulaceae, contain pollen allergens structurally or immuno logically related to those of the olive tree. This fact allows to detect an d evaluate antigenic cross-reactivities involving olive allergens. The aim of this research is the development of new diagnostic tools for olive polli nosis and new approaches to improve the classical immunotherapy. Copyright (C) 2001 S. Karger AG, Basel.